183 related articles for article (PubMed ID: 10945959)
1. Vitamin E succinate promotes breast cancer tumor dormancy.
Malafa MP; Neitzel LT
J Surg Res; 2000 Sep; 93(1):163-70. PubMed ID: 10945959
[TBL] [Abstract][Full Text] [Related]
2. Vitamin E succinate (VES) induces Fas sensitivity in human breast cancer cells: role for Mr 43,000 Fas in VES-triggered apoptosis.
Yu W; Israel K; Liao QY; Aldaz CM; Sanders BG; Kline K
Cancer Res; 1999 Feb; 59(4):953-61. PubMed ID: 10029090
[TBL] [Abstract][Full Text] [Related]
3. The therapeutic and preventive effect of RRR-alpha-vitamin E succinate on prostate cancer via induction of insulin-like growth factor binding protein-3.
Yin Y; Ni J; Chen M; DiMaggio MA; Guo Y; Yeh S
Clin Cancer Res; 2007 Apr; 13(7):2271-80. PubMed ID: 17404112
[TBL] [Abstract][Full Text] [Related]
4. Differential response of human ovarian cancer cells to induction of apoptosis by vitamin E Succinate and vitamin E analogue, alpha-TEA.
Anderson K; Simmons-Menchaca M; Lawson KA; Atkinson J; Sanders BG; Kline K
Cancer Res; 2004 Jun; 64(12):4263-9. PubMed ID: 15205340
[TBL] [Abstract][Full Text] [Related]
5. Activation of extracellular signal-regulated kinase and c-Jun-NH(2)-terminal kinase but not p38 mitogen-activated protein kinases is required for RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells.
Yu W; Liao QY; Hantash FM; Sanders BG; Kline K
Cancer Res; 2001 Sep; 61(17):6569-76. PubMed ID: 11522656
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
[TBL] [Abstract][Full Text] [Related]
7. Vitamin E and the Y4 agonist BA-129 decrease prostate cancer growth and production of vascular endothelial growth factor.
Yu A; Somasundar P; Balsubramaniam A; Rose AT; Vona-Davis L; McFadden DW
J Surg Res; 2002 Jun; 105(1):65-8. PubMed ID: 12069504
[TBL] [Abstract][Full Text] [Related]
8. RRR-alpha-tocopheryl succinate enhances TGF-beta 1, -beta 2, and -beta 3 and TGF-beta R-II expression by human MDA-MB-435 breast cancer cells.
Charpentier A; Simmons-Menchaca M; Yu W; Zhao B; Qian M; Heim K; Sanders BG; Kline K
Nutr Cancer; 1996; 26(2):237-50. PubMed ID: 8875561
[TBL] [Abstract][Full Text] [Related]
9. RRR-alpha-tocopheryl succinate induces MDA-MB-435 and MCF-7 human breast cancer cells to undergo differentiation.
You H; Yu W; Sanders BG; Kline K
Cell Growth Differ; 2001 Sep; 12(9):471-80. PubMed ID: 11571230
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo anticancer effects of the novel vitamin E ether analogue RRR-alpha-tocopheryloxybutyl sulfonic acid in prostate cancer.
Ni J; Mai T; Pang ST; Haque I; Huang K; DiMaggio MA; Xie S; James NS; Kasi D; Chemler SR; Yeh S
Clin Cancer Res; 2009 Feb; 15(3):898-906. PubMed ID: 19188160
[TBL] [Abstract][Full Text] [Related]
11. Importance of VEGF for breast cancer angiogenesis in vivo: implications from intravital microscopy of combination treatments with an anti-VEGF neutralizing monoclonal antibody and doxorubicin.
Borgström P; Gold DP; Hillan KJ; Ferrara N
Anticancer Res; 1999; 19(5B):4203-14. PubMed ID: 10628376
[TBL] [Abstract][Full Text] [Related]
12. RRR-alpha-tocopheryl succinate induction of DNA synthesis arrest of human MDA-MB-435 cells involves TGF-beta-independent activation of p21Waf1/Cip1.
Yu W; Sanders BG; Kline K
Nutr Cancer; 2002; 43(2):227-36. PubMed ID: 12588702
[TBL] [Abstract][Full Text] [Related]
13. Involvement of activator protein-1 (AP-1) in induction of apoptosis by vitamin E succinate in human breast cancer cells.
Zhao B; Yu W; Qian M; Simmons-Menchaca M; Brown P; Birrer MJ; Sanders BG; Kline K
Mol Carcinog; 1997 Jul; 19(3):180-90. PubMed ID: 9254885
[TBL] [Abstract][Full Text] [Related]
14. Vitamin E succinate induces Fas-mediated apoptosis in estrogen receptor-negative human breast cancer cells.
Turley JM; Fu T; Ruscetti FW; Mikovits JA; Bertolette DC; Birchenall-Roberts MC
Cancer Res; 1997 Mar; 57(5):881-90. PubMed ID: 9041190
[TBL] [Abstract][Full Text] [Related]
15. Peptide YY augments gross inhibition by vitamin E succinate of human pancreatic cancer cell growth.
Heisler T; Towfigh S; Simon N; Liu C; McFadden DW
J Surg Res; 2000 Jan; 88(1):23-5. PubMed ID: 10644462
[TBL] [Abstract][Full Text] [Related]
16. Decreased vascular endothelial growth factor expression associated with tumor regression induced by (E)-2'-deoxy-2'-(fluoromethylene)cytidine (MDL 101,731).
Woessner RD; Loudy DE; Wallace CD; Montgomery LR; Cross-Doersen DE; Bush TL; Lewis MT; Prakash N; Bitonti AJ; Wright PS
Oncol Res; 1997; 9(10):543-52. PubMed ID: 9507532
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of proliferation of PC-3 human prostate cancer by antagonists of growth hormone-releasing hormone: lack of correlation with the levels of serum IGF-I and expression of tumoral IGF-II and vascular endothelial growth factor.
Plonowski A; Schally AV; Letsch M; Krupa M; Hebert F; Busto R; Groot K; Varga JL
Prostate; 2002 Aug; 52(3):173-82. PubMed ID: 12111694
[TBL] [Abstract][Full Text] [Related]
18. [Inhibitation of tumor angiogenesis, growth and metastasis by blocking VEGF paracrine pathway].
Wang F; Tian YH; Li L; Chen XF; Hu HH; Li CY; Huang Q
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2002 Mar; 34(2):165-70. PubMed ID: 12006990
[TBL] [Abstract][Full Text] [Related]
19. Broad antitumor activity in breast cancer xenografts by motesanib, a highly selective, oral inhibitor of vascular endothelial growth factor, platelet-derived growth factor, and Kit receptors.
Coxon A; Bush T; Saffran D; Kaufman S; Belmontes B; Rex K; Hughes P; Caenepeel S; Rottman JB; Tasker A; Patel V; Kendall R; Radinsky R; Polverino A
Clin Cancer Res; 2009 Jan; 15(1):110-8. PubMed ID: 19118038
[TBL] [Abstract][Full Text] [Related]
20. Vitamin E succinate decreases lung cancer tumor growth in mice.
Quin J; Engle D; Litwiller A; Peralta E; Grasch A; Boley T; Hazelrigg S
J Surg Res; 2005 Aug; 127(2):139-43. PubMed ID: 16083751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
